BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3248806)

  • 1. Comparative study of oxprenolol and atenolol in the treatment of hypertension.
    Kamili MA; Allaqaband GQ; Ali G; Shah MY; Sheikh AS
    Indian Heart J; 1988; 40(6):471-4. PubMed ID: 3248806
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical value of selective beta 1 block in antihypertensive therapy].
    Marata AM; Montebugnoli L; Costa FV; Rosati G; Ambrosioni E; Magnani B
    Boll Soc Ital Cardiol; 1981; 26(11):1919-25. PubMed ID: 7349265
    [No Abstract]   [Full Text] [Related]  

  • 5. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
    Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
    Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxprenolol in hypertension.
    Marshall AJ; Barritt DW
    Br J Clin Pract; 1973 Sep; 27(9):337-40. PubMed ID: 4595073
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.
    Kjeldsen SE; Eide I; Aakesson I; Amundsen R; Eriksen IL; Leren P
    Acta Med Scand; 1983; 214(5):367-71. PubMed ID: 6660046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA
    Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Withdrawal syndrome following beta blocker therapy (author's transl)].
    Hausen T
    MMW Munch Med Wochenschr; 1981 Oct; 123(42):1583-4. PubMed ID: 6796833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the hypotensive effect of a combination of oxprenolol-chlortalidone with single and fractionated administration].
    Rubegni M; Provvedi D; Bandinelli C; Bellini PG; De Mauro G
    Boll Soc Ital Cardiol; 1976; 21(10):1853-8. PubMed ID: 1031614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atenolol and metoprolol in the treatment of slight to moderate hypertension. A comparative study].
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Ugeskr Laeger; 1982 Dec; 144(51):2823-6. PubMed ID: 6762745
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
    Andersson O; Berglund G; Bergman H; Cramér K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Lakartidningen; 1975 Nov; 72(48):4738-40. PubMed ID: 1105030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation in the treatment of arterial hypertension between prolonged-action clonidine and atenolol].
    La Vecchia M; Vergara G; Iannuzzi G; Simonetti A; Cimmino G; Saulino C; Novelli Genuino G; Valerio V
    Clin Ter; 1985 Dec; 115(6):443-8. PubMed ID: 3830543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihypertensive efficacy of atenolol].
    Huang ZQ; Liu LH; Xue SH; Zheng DY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):245-7. PubMed ID: 6217916
    [No Abstract]   [Full Text] [Related]  

  • 18. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
    Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.